CVS Health (CVS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on CVS Health (CVS) is Neutral.

The composite score behind that read is -0.08, weighing +0.23 of bullish evidence against -0.34 bearish.

CVS Health last closed at $86.16, -1.87% on the session.

Against the IVW growth benchmark the position is -2.67% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

15 graded predictions for CVS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks CVS Health in the 39th percentile on valuation and the 51st percentile on return on equity, where 100 is best.

CVS Health is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $112.29B.

StockMap tracks CVS Health as the 2nd largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite CVS Health ranks 64th of 85 in the group, against a group median of +0.00.